Contents
About this issue
This issue of CRIA Update focuses on some of the most important concerns facing people who are co-infected with HIV and Hepatitis C. First, Irene Cergnul, MD, one of CRIA’s study coordinators, offers a brief introduction to hepatitis discussing what it is and its many causes. Next, Douglas Dieterich, MD, renowned HEP C researcher, clinician and CRIA Board member, along with regular contributor Tim Horn, explore the complexities of HIV/HEP C co-infection. James Learned of Hepatitis-C Action and Advocacy Coalition (HAAC) in New York, discusses some of the ways in which HEP C is diagnosed and monitored throughout the course of disease.
To help readers understand what the treatment landscape looks like-both now and in the near future, Tim Horn has summarized much of what is known about interferon therapy, the new antiviral ribavirin, and some of the novel therapeutics in development. Finally, CRIA’s Managing Editor, David Pieribone presents a common sense guide to liver health. We hope that the information in this issue, along with regular health care, will allow individuals who are co-infected with HIV and HEP C and their caregivers to better understand their disease and, with the help of their doctor, make the most appropriate treatments decisions.
